logo/base Created with Sketch.

FibroScan PRO®

The complete non-invasive solution for advanced liver disease assessment, with embedded Ultrasound Guidance option to pre-locate the liver position.

Powered by LSM by VCTE™ and CAP™ for liver fibrosis and liver steatosis assessment.

wave

FibroScan PRO® is designed for specialized centers in mid/large hospitals with heavy examination needs and managing complex/advanced cases.

 

Accuracy with C-FGP probe

The C-FGP probe is used to pre-locate an optimal measurement area in the liver.

 

Ergonomic design

LSM by VCTE™ is unique, patented and validated for liver fibrosis assessment. It is the standard for non-invasive evaluation of liver stiffness with 2,250 international peer-reviewed publications.1

CAP™ is unique patented and validated for liver steatosis assessment2,3 with 330 international peer-reviewed publications. 

What our users say

quote

Assessment of liver stiffness and fat by non-invasive method is a huge step forward towards better management of NAFLD. It has hugely impacted the way clinicians stratify the patients, chose therapy and monitor response!

Akash Shukla | Professor & Head Department of Gastroenterology Seth GSMC & KEM Hospital Mumbai

chevron chevron

Products in the FibroScan® range are Class IIa medical devices as defined by Directive 93/42/EEC (EC 0459). These devices are designed for use in a medical practice in order to measure liver stiffness and ultrasound attenuation in patients with liver disease. Examinations with FibroScan® device shall be performed by an operator who has been certified by the manufacturer or its approved local representative. Operators are expressly recommended to carefully read the instructions given in the user manual and on the labelling of these products. Check cost defrayal conditions with paying bodies.

 

References are available in our bibliography.